Cargando…

The Development of a Novel Therapeutic Strategy to Target Hyaluronan in the Extracellular Matrix of Pancreatic Ductal Adenocarcinoma

Pancreatic ductal adenocarcinoma (PDAC) is one of the most lethal diseases to affect humans, regardless of whether patients receive multimodal therapy (including surgery, radiotherapy, and chemotherapy). This resistance to intervention is currently considered to be caused by the desmoplastic change...

Descripción completa

Detalles Bibliográficos
Autores principales:	Kudo, Daisuke, Suto, Akiko, Hakamada, Kenichi
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2017
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5372616/ https://www.ncbi.nlm.nih.gov/pubmed/28282922 http://dx.doi.org/10.3390/ijms18030600

Ejemplares similares

4-Methylumbelliferone Suppresses Hyaluronan Synthesis and Tumor Progression in SCID Mice Intra-abdominally Inoculated With Pancreatic Cancer Cells
por: Nagase, Hayato, et al.
Publicado: (2017)

Antitumor effects of the hyaluronan inhibitor 4-methylumbelliferone on pancreatic cancer
por: Yoshida, Eri, et al.
Publicado: (2016)

Targeting hyaluronan for the treatment of pancreatic ductal adenocarcinoma
por: Sato, Norihiro, et al.
Publicado: (2016)

Hyaluronan activated-metabolism phenotype (HAMP) in pancreatic ductal adenocarcinoma
por: Kudo, Yuzan, et al.
Publicado: (2019)

Prognostic and functional role of hyaluronan-binding protein 1 in pancreatic ductal adenocarcinoma
por: Adachi, Yasuhiro, et al.
Publicado: (2022)

Prognostic Impact of Hyaluronan and Its Regulators in Pancreatic Ductal Adenocarcinoma
por: Cheng, Xiao-Bo, et al.
Publicado: (2013)

Is hyaluronan deposition in the stroma of pancreatic ductal adenocarcinoma of prognostic significance?
por: Gebauer, Florian, et al.
Publicado: (2017)

Non-Invasive Monitoring of Stromal Biophysics with Targeted Depletion of Hyaluronan in Pancreatic Ductal Adenocarcinoma
por: Maloney, Ezekiel, et al.
Publicado: (2019)

Diabetes in Humans Activates Pancreatic Stellate Cells via RAGE in Pancreatic Ductal Adenocarcinoma
por: Uchida, Chiaki, et al.
Publicado: (2021)

Monocarboxylate Transporters Are Involved in Extracellular Matrix Remodelling in Pancreatic Ductal Adenocarcinoma
por: Ufuk, Ayşe, et al.
Publicado: (2022)

Essential updates 2018/2019: Current topics in the surgical treatment of pancreatic ductal adenocarcinoma
por: Ishido, Keinosuke, et al.
Publicado: (2020)

Therapeutic Targeting of Autophagy in Pancreatic Ductal Adenocarcinoma
por: Raufi, Alexander G., et al.
Publicado: (2021)

Therapeutic Status and Available Strategies in Pancreatic Ductal Adenocarcinoma
por: Thakur, Gitika, et al.
Publicado: (2021)

Stroma Involvement in Pancreatic Ductal Adenocarcinoma: An Overview Focusing on Extracellular Matrix Proteins
por: Liot, Sophie, et al.
Publicado: (2021)

Heterogeneity of metabolic adaptive capacity affects the prognosis among pancreatic ductal adenocarcinomas
por: Kanda, Taishu, et al.
Publicado: (2022)

Schlafen 5 as a Novel Therapeutic Target in Pancreatic Ductal Adenocarcinoma
por: Fischietti, Mariafausta, et al.
Publicado: (2021)

Diabetes mellitus impacts on expression of DNA mismatch repair protein PMS2 and tumor microenvironment in pancreatic ductal adenocarcinoma
por: Pan, Xuekai, et al.
Publicado: (2022)

Targets (Metabolic Mediators) of Therapeutic Importance in Pancreatic Ductal Adenocarcinoma
por: Rai, Vikrant, et al.
Publicado: (2020)

Clinical Strategies Targeting the Tumor Microenvironment of Pancreatic Ductal Adenocarcinoma
por: Skorupan, Nebojsa, et al.
Publicado: (2022)

Nanoparticle-Based Therapeutic Strategies for Enhanced Pancreatic Ductal Adenocarcinoma Immunotherapy
por: Hou, Wanting, et al.
Publicado: (2022)

Dual epigenetic changes in diabetes mellitus‐associated pancreatic ductal adenocarcinoma correlate with downregulation of E‐cadherin and worsened prognosis
por: Hara, Yutaro, et al.
Publicado: (2023)

Emerging Kinase Therapeutic Targets in Pancreatic Ductal Adenocarcinoma and Pancreatic Cancer Desmoplasia
por: Creeden, Justin F., et al.
Publicado: (2020)

Human ductal adenocarcinomas of the pancreas express extracellular matrix proteins.
por: Löhr, M., et al.
Publicado: (1994)

Inhibition of geranylgeranyl diphosphate synthase is a novel therapeutic strategy for pancreatic ductal adenocarcinoma
por: Haney, Staci L., et al.
Publicado: (2019)

Use of time‑density curves of dynamic contrast‑enhanced computed tomography for determination of the histological therapeutic effects of neoadjuvant chemotherapy for pancreatic ductal adenocarcinoma
por: Goto, Shintaro, et al.
Publicado: (2023)

Besieging the Tumoral Sites: Could It Be an Alternative Therapeutic Strategy in Ductal Pancreatic Adenocarcinoma?
por: Delma, Mohamed Islam
Publicado: (2020)

The Proteoglycan Glypican-1 as a Possible Candidate for Innovative Targeted Therapeutic Strategies for Pancreatic Ductal Adenocarcinoma
por: Busato, Davide, et al.
Publicado: (2022)

Super-enhancers: novel target for pancreatic ductal adenocarcinoma
por: Ghosh, Chandrayee, et al.
Publicado: (2019)

Splice variants as novel targets in pancreatic ductal adenocarcinoma
por: Wang, Jun, et al.
Publicado: (2017)

Identification of GRIN2D as a novel therapeutic target in pancreatic ductal adenocarcinoma
por: Wang, Jiatong, et al.
Publicado: (2023)

The extracellular matrix and focal adhesion kinase signaling regulate cancer stem cell function in pancreatic ductal adenocarcinoma
por: Begum, Asma, et al.
Publicado: (2017)

Prediction of early recurrence of pancreatic ductal adenocarcinoma after resection
por: Sugawara, Toshitaka, et al.
Publicado: (2021)

Non-Invasive Monitoring of Increased Fibrotic Tissue and Hyaluronan Deposition in the Tumor Microenvironment in the Advanced Stages of Pancreatic Ductal Adenocarcinoma
por: Vohra, Ravneet, et al.
Publicado: (2022)

RNA Binding Proteins as Drivers and Therapeutic Target Candidates in Pancreatic Ductal Adenocarcinoma
por: Glaß, Markus, et al.
Publicado: (2020)

Cancer-Associated Fibroblasts in Pancreatic Ductal Adenocarcinoma: An Update on Heterogeneity and Therapeutic Targeting
por: Vaish, Utpreksha, et al.
Publicado: (2021)

Targeting histone deacetylases in pancreatic ductal adenocarcinoma
por: Schneider, Günter, et al.
Publicado: (2010)

Targeting Pancreatic Ductal Adenocarcinoma Acidic Microenvironment
por: Cruz-Monserrate, Zobeida, et al.
Publicado: (2014)

Targeting mTOR in Pancreatic Ductal Adenocarcinoma
por: Iriana, Sentia, et al.
Publicado: (2016)

Targeting dendritic cells in pancreatic ductal adenocarcinoma
por: Deicher, Anton, et al.
Publicado: (2018)

Hydrogel-Based Therapeutics for Pancreatic Ductal Adenocarcinoma Treatment
por: Liu, Jinlu, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_dog5e8n0aogl3pe0p6sa03rjs2